Skip to content

Continuous positive airway pressure in severe Covid-19 pneumonia

Continuous positive airway pressure in severe Covid-19 pneumonia: a feasibility and physiological end-point study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON28307
Enrollment
13
Registered
2020-04-13
Start date
2020-05-08
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corona virus disease 2019 (Covid-19), proven with PCR on nasopharyngeal swab and with matching abnormalities on low-dose CT-scan

Interventions

Three conditions are tested (each lasting 30 min, the ‘measurement period’): 1. Oxygen delivery via a nonrebreathing mask (current standard of care) with sufficient inflow of O2 (which does not creat

Sponsors

Raad van Bestuur van het AMC (Amsterdam)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A subject must meet all of the following criteria: - age > 18 years - Positive for Covid-19 (CORADS 5, i.e. highly likely Covid-19 on the low-dose CT scan, or PCR positive nasopharyngeal swab for SARS Coronavirus 2). - Admitted to Amsterdam UMC, location AMC. - A transcutaneous O2 saturation (SpO2) of 90% or less at 5 l/min oxygen administration via nasal canula. - Provide informed consent.

Exclusion criteria

Exclusion criteria: - Hypercapnia (defined as arterial PCO2 > 6.0 kPa or 45 mmHg) - A history of moderate to severe Chronic Obstructive Pulmonary Disease (COPD, GOLD severity III or IV), restrictive lung disease, or Obesity Hypoventilation Syndrome - Need for intubation or admission to the Intensive Care Unit as determined by the responsible physician - Palliative care - Reduced consciousness - Vomiting - Unability to wear the mask due to anatomical / physical restriction (e.g. facial operations; bearded) - Unable to provide informed consent.

Design outcomes

Primary

MeasureTime frame
A change in the two-dimensional variable (SpO2, RR), the combination of oxygen saturation and respiratory rate. SpO2 is measured with a pulse oximeter and RR is derived from the pressure changes in the mouth compartment of the mask.

Secondary

MeasureTime frame
1. Patient satisfaction score and Borg dyspnoea scale 2. System performance: Stability of O2 delivery and CO2 build-up in the mask during the 30-min recording time (measured as the mean inspiratory PO2 and PCO2, respectively). 3. Respiration: tidal volume, minimal negative pressure in the mouth compartment during inspiration (as a measure of inspiratory work of breathing), end-tidal and mixed-expiratory PO2 and PCO2 (as measures of pulmonary gas exchange). 4. Circulation: heart rate 5. Adverse events: painscore, decubitus, CO2 rebreathing, choking, mask malfunction otherwise

Contacts

Public ContactJoost van den Aardweg

Amsterdam UMC, location AMC

j.g.vandenaardweg@amsterdamumc.nl020-5669111

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)